Highlights

  • PME signs three new Cloud contracts carrying a combined minimum value of AUD 29M.
  • Agreements span paediatric care, cancer research, and regional clinical services in North America.
  • New deals lift first-half FY26 minimum total contract value to AUD 273M.

Pro Medicus Limited (ASX:PME) announced that its U.S. subsidiary, Visage Imaging Inc., has entered into three new customer contracts with a combined minimum value of AUD 29M. All three agreements will be implemented on a Cloud and Full-Stack model. The company stated that these deployments are planned for completion within the next six months.

Contract Breakdown Across Healthcare Providers

The newly secured contracts cover three different healthcare organisations across the United States and Canada.
A AUD 6.5M, five-year agreement has been signed with Children’s of Alabama, a paediatric hospital located in Birmingham, Alabama.

A AUD 9.5M, seven-year contract has been finalised with Roswell Park Comprehensive Cancer Center, a cancer research and treatment institution based in Buffalo, New York.

A AUD 13M, seven-year deal has been signed with Vancouver Clinic, a physician-owned and governed healthcare group situated in Vancouver, Southwest Washington.

Broader Market Coverage

The company noted that the three new clients include a children’s hospital, a cancer centre, and a physician-owned regional provider. According to the company, this range reflects engagement across multiple segments of the market, covering smaller groups through to larger integrated delivery networks and academic medical centres in the U.S.

Updated First-Half FY26 Contract Value

With the addition of these agreements, the minimum total contract value (TCV) generated for the first half of FY26 has reached AUD 273M. The company reported that opportunities continue across various deal sizes and market categories.

Upcoming Industry Event

The company also referenced its participation in the RSNA conference scheduled in Chicago later this month. It stated that the event is expected to be significant for its ongoing activities in the imaging technology sector.

Share Price Snapshot

PME was trading 4.60% higher at AUD 262.89 per share as of 24 November 2025.